IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8 + T-cell tumour infiltration

Abstract Background Interleukin-17A (IL-17A), a proinflammatory cytokine primarily secreted by Th17 cells, γδT cells and natural killer T (NKT) cells, performs essential roles in the microenvironment of certain inflammation-related tumours by regulating cancer growth and tumour elimination proved in...

Full description

Bibliographic Details
Main Authors: Wen-Qing Feng, Yu-Chen Zhang, Zhuo-Qing Xu, Su-Yue Yu, Jian-ting Huo, Abudumaimaitijiang Tuersun, Min-Hua Zheng, Jing-Kun Zhao, Ya-Ping Zong, Ai-Guo Lu
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-023-04187-3
_version_ 1797822697317597184
author Wen-Qing Feng
Yu-Chen Zhang
Zhuo-Qing Xu
Su-Yue Yu
Jian-ting Huo
Abudumaimaitijiang Tuersun
Min-Hua Zheng
Jing-Kun Zhao
Ya-Ping Zong
Ai-Guo Lu
author_facet Wen-Qing Feng
Yu-Chen Zhang
Zhuo-Qing Xu
Su-Yue Yu
Jian-ting Huo
Abudumaimaitijiang Tuersun
Min-Hua Zheng
Jing-Kun Zhao
Ya-Ping Zong
Ai-Guo Lu
author_sort Wen-Qing Feng
collection DOAJ
description Abstract Background Interleukin-17A (IL-17A), a proinflammatory cytokine primarily secreted by Th17 cells, γδT cells and natural killer T (NKT) cells, performs essential roles in the microenvironment of certain inflammation-related tumours by regulating cancer growth and tumour elimination proved in previous literature. In this study, the mechanism of IL-17A that induces mitochondrial dysfunction promoted pyroptosis has been explored in colorectal cancer cells. Method The records of 78 patients diagnosed with CRC were reviewed via the public database to evaluate clinicopathological parameters and prognosis associations of IL-17A expression. The colorectal cancer cells were treated with IL-17A, and the morphological characteristics of those cells were indicated by scanning electron microscope and transmission electron microscope. After IL-17A treatment, mitochondrial dysfunction was tested by mitochondrial membrane potential (MMP) and reactive oxygen species (ROS). The expression of pyroptosis associated proteins including cleaved caspase-4, cleaved gasdermin-D (GSDMD), IL-1β, receptor activator of nuclear NOD-like receptor family pyrin domain containing 3 (NLRP3), apoptosis-associated speck like protein containing a card (ASC), and factor-kappa B was measured through western blotting. Results Positive IL-17A protein expression was observed in CRC compared to the non-tumour tissue. IL-17A expression indicates a better differentiation, earlier stage, and better overall survival in CRC. IL-17A treatment could induce mitochondrial dysfunction and stimulate intracellular reactive oxygen species (ROS) production. Furthermore, IL-17A could promote pyroptosis of colorectal cancer cells and significantly increase the secretion of inflammatory factors. Nevertheless, the pyroptosis induced by IL-17A could be inhibited through the pre-treatment with Mito-TEMPO (a mitochondria-targeted superoxide dismutase mimetic with superoxide and alkyl radical scavenging properties) or Z-LEVD-FMK (caspase-4 inhibitor, fluoromethylketone). Additionally, after being treated with IL-17A, an increasing number of CD8 + T cells showed in mouse-derived allograft colon cancer models. Conclusion IL-17A, as a cytokine mainly secreted by γδT cells in the colorectal tumour immune microenvironment, can regulate the tumour microenvironment in multiple ways. IL-17A could induce mitochondrial dysfunction and pyroptosis through the ROS/NLRP3/caspase-4/GSDMD pathway, and promote intracellular ROS accumulation. In addition, IL-17A can promote the secretion of inflammatory factors such as IL-1β、IL-18 and immune antigens, and recruit CD8 + T cells to infiltrate tumours. Graphical Abstract
first_indexed 2024-03-13T10:12:57Z
format Article
id doaj.art-cb51319b20d04e3ea9781aaa21ee1e4b
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-03-13T10:12:57Z
publishDate 2023-05-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-cb51319b20d04e3ea9781aaa21ee1e4b2023-05-21T11:25:41ZengBMCJournal of Translational Medicine1479-58762023-05-0121111710.1186/s12967-023-04187-3IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8 + T-cell tumour infiltrationWen-Qing Feng0Yu-Chen Zhang1Zhuo-Qing Xu2Su-Yue Yu3Jian-ting Huo4Abudumaimaitijiang Tuersun5Min-Hua Zheng6Jing-Kun Zhao7Ya-Ping Zong8Ai-Guo Lu9Department of General Surgery, Shanghai Minimally Invasive Surgery Center, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of General Surgery, Shanghai Minimally Invasive Surgery Center, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of General Surgery, Shanghai Minimally Invasive Surgery Center, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of General Surgery, Shanghai Minimally Invasive Surgery Center, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of General Surgery, Shanghai Minimally Invasive Surgery Center, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of General Surgery, Shanghai Minimally Invasive Surgery Center, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of General Surgery, Shanghai Minimally Invasive Surgery Center, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of General Surgery, Shanghai Minimally Invasive Surgery Center, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of General Surgery, Shanghai Minimally Invasive Surgery Center, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of General Surgery, Shanghai Minimally Invasive Surgery Center, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineAbstract Background Interleukin-17A (IL-17A), a proinflammatory cytokine primarily secreted by Th17 cells, γδT cells and natural killer T (NKT) cells, performs essential roles in the microenvironment of certain inflammation-related tumours by regulating cancer growth and tumour elimination proved in previous literature. In this study, the mechanism of IL-17A that induces mitochondrial dysfunction promoted pyroptosis has been explored in colorectal cancer cells. Method The records of 78 patients diagnosed with CRC were reviewed via the public database to evaluate clinicopathological parameters and prognosis associations of IL-17A expression. The colorectal cancer cells were treated with IL-17A, and the morphological characteristics of those cells were indicated by scanning electron microscope and transmission electron microscope. After IL-17A treatment, mitochondrial dysfunction was tested by mitochondrial membrane potential (MMP) and reactive oxygen species (ROS). The expression of pyroptosis associated proteins including cleaved caspase-4, cleaved gasdermin-D (GSDMD), IL-1β, receptor activator of nuclear NOD-like receptor family pyrin domain containing 3 (NLRP3), apoptosis-associated speck like protein containing a card (ASC), and factor-kappa B was measured through western blotting. Results Positive IL-17A protein expression was observed in CRC compared to the non-tumour tissue. IL-17A expression indicates a better differentiation, earlier stage, and better overall survival in CRC. IL-17A treatment could induce mitochondrial dysfunction and stimulate intracellular reactive oxygen species (ROS) production. Furthermore, IL-17A could promote pyroptosis of colorectal cancer cells and significantly increase the secretion of inflammatory factors. Nevertheless, the pyroptosis induced by IL-17A could be inhibited through the pre-treatment with Mito-TEMPO (a mitochondria-targeted superoxide dismutase mimetic with superoxide and alkyl radical scavenging properties) or Z-LEVD-FMK (caspase-4 inhibitor, fluoromethylketone). Additionally, after being treated with IL-17A, an increasing number of CD8 + T cells showed in mouse-derived allograft colon cancer models. Conclusion IL-17A, as a cytokine mainly secreted by γδT cells in the colorectal tumour immune microenvironment, can regulate the tumour microenvironment in multiple ways. IL-17A could induce mitochondrial dysfunction and pyroptosis through the ROS/NLRP3/caspase-4/GSDMD pathway, and promote intracellular ROS accumulation. In addition, IL-17A can promote the secretion of inflammatory factors such as IL-1β、IL-18 and immune antigens, and recruit CD8 + T cells to infiltrate tumours. Graphical Abstracthttps://doi.org/10.1186/s12967-023-04187-3IL-17AColorectal cancerMitochondrial dysfunctionPyroptosisCD8 + T
spellingShingle Wen-Qing Feng
Yu-Chen Zhang
Zhuo-Qing Xu
Su-Yue Yu
Jian-ting Huo
Abudumaimaitijiang Tuersun
Min-Hua Zheng
Jing-Kun Zhao
Ya-Ping Zong
Ai-Guo Lu
IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8 + T-cell tumour infiltration
Journal of Translational Medicine
IL-17A
Colorectal cancer
Mitochondrial dysfunction
Pyroptosis
CD8 + T
title IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8 + T-cell tumour infiltration
title_full IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8 + T-cell tumour infiltration
title_fullStr IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8 + T-cell tumour infiltration
title_full_unstemmed IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8 + T-cell tumour infiltration
title_short IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8 + T-cell tumour infiltration
title_sort il 17a mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes cd8 t cell tumour infiltration
topic IL-17A
Colorectal cancer
Mitochondrial dysfunction
Pyroptosis
CD8 + T
url https://doi.org/10.1186/s12967-023-04187-3
work_keys_str_mv AT wenqingfeng il17amediatedmitochondrialdysfunctioninducespyroptosisincolorectalcancercellsandpromotescd8tcelltumourinfiltration
AT yuchenzhang il17amediatedmitochondrialdysfunctioninducespyroptosisincolorectalcancercellsandpromotescd8tcelltumourinfiltration
AT zhuoqingxu il17amediatedmitochondrialdysfunctioninducespyroptosisincolorectalcancercellsandpromotescd8tcelltumourinfiltration
AT suyueyu il17amediatedmitochondrialdysfunctioninducespyroptosisincolorectalcancercellsandpromotescd8tcelltumourinfiltration
AT jiantinghuo il17amediatedmitochondrialdysfunctioninducespyroptosisincolorectalcancercellsandpromotescd8tcelltumourinfiltration
AT abudumaimaitijiangtuersun il17amediatedmitochondrialdysfunctioninducespyroptosisincolorectalcancercellsandpromotescd8tcelltumourinfiltration
AT minhuazheng il17amediatedmitochondrialdysfunctioninducespyroptosisincolorectalcancercellsandpromotescd8tcelltumourinfiltration
AT jingkunzhao il17amediatedmitochondrialdysfunctioninducespyroptosisincolorectalcancercellsandpromotescd8tcelltumourinfiltration
AT yapingzong il17amediatedmitochondrialdysfunctioninducespyroptosisincolorectalcancercellsandpromotescd8tcelltumourinfiltration
AT aiguolu il17amediatedmitochondrialdysfunctioninducespyroptosisincolorectalcancercellsandpromotescd8tcelltumourinfiltration